Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial

Ophthalmology

Volumn 108, Issue 7, 2001, Pages 1179-1183

  Asaria, Riaz Hassan Yusuf ^a,b   Kon, Chee Hing ^a,b   Bunce, Catey ^a   Charteris, David G ^a,b   Wong, David ^c   Khaw, Peng Tee ^a,b   Aylward, George William ^a,b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RETINA DETACHMENT; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY;

EID: 0034977919     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00589-9     Document Type: Article

References (34)

1. Changing concepts of failures after retinal detachment surgery
2. The classification of retinal detachment with proliferative vitreoretinopathy
3. Proliferative vitreoretinopathy - Is ir anything more than wound healing at the wrong place?
4. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy
5. Cytokines in proliferative vitreoretinopathy
6. Expression of vitreous cytokines in proliferative vitreoretinopathy: A prospective study
7. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy
8. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells
9. The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy
10. Effects of vitamin A on retinal pigment epithelial cells in vitro
11. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages
12. Glucocorticosteroid inhibition of intraocular proliferation after injury
13. Inhibition of intraocular proliferations with intravitreal corticosteroids
14. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy
15. Oral colchicine for the treatment of experimental traction retinal detachment
16. Taxol treatment of experimental proliferative vitreoretinopathy
17. Taxol for the treatment of proliferative vitreoretinopathy
18. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy
19. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy
20. Fluorouracil for the treatment of massive periretinal proliferation
21. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy
22. 5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite
23. Ocular toxicity of fluorouracil after vitrectomy
24. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases
25. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts
26. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C
27. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts
28. Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: Implications for the treatment of proliferative vitreoretinopathy
29. Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy
30. A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin
31. An overview of potential applications of heparin in vitreoretinal surgery
32. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: A prospective study
33. An updated classification of retinal detachment with proliferative vitreoretinopathy
34. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: Results of a multicenter clinical trial